Acute migraine attacks

E. Anne Macgregor, Rashmi B. Halker, Bert B. Vargas

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Headache is the most common neurological condition in the world, with more than 90% of the population reporting headaches at some time in their lives. Among primary headache disorders, tension-type headache is the most prevalent worldwide, but in patients seeking medical help, migraine is by far the most frequently presenting headache subtype. Migraine is more prevalent than diabetes, epilepsy, and asthma combined. Prophylactic drugs aim to reduce the frequency of migraine attacks, their duration, and their severity. Agents used include antihypertensives (including beta-blockers and calcium-channel blockers), antidepressants, anticonvulsants, and NSAIDs. A number of physical treatments for migraine have been studied, including transcutaneous electrical nerve stimulation (TENS), occlusal adjustment, cervical manipulation, and acupuncture. There is extensive clinical experience of using beta-blockers in the prophylaxis of migraine. In general, the prognosis of migraine is favorable.

Original languageEnglish (US)
Title of host publicationEvidence-Based Neurology
Subtitle of host publicationManagement of Neurological Disorders: Second Edition
PublisherWiley Blackwell
Pages267-278
Number of pages12
ISBN (Electronic)9781119067344
ISBN (Print)9780470657782
DOIs
StatePublished - Dec 11 2015

Fingerprint

Migraine Disorders
Headache
Occlusal Adjustment
Primary Headache Disorders
Spinal Manipulation
Transcutaneous Electric Nerve Stimulation
Tension-Type Headache
Calcium Channel Blockers
Non-Steroidal Anti-Inflammatory Agents
Acupuncture
Anticonvulsants
Antihypertensive Agents
Antidepressive Agents
Epilepsy
Asthma
Pharmaceutical Preparations
Population

Keywords

  • Acute migraine attacks
  • Antidepressants
  • Beta-blockers
  • Headache
  • NSAIDs

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Anne Macgregor, E., Halker, R. B., & Vargas, B. B. (2015). Acute migraine attacks. In Evidence-Based Neurology: Management of Neurological Disorders: Second Edition (pp. 267-278). Wiley Blackwell. https://doi.org/10.1002/9781119067344.ch26

Acute migraine attacks. / Anne Macgregor, E.; Halker, Rashmi B.; Vargas, Bert B.

Evidence-Based Neurology: Management of Neurological Disorders: Second Edition. Wiley Blackwell, 2015. p. 267-278.

Research output: Chapter in Book/Report/Conference proceedingChapter

Anne Macgregor, E, Halker, RB & Vargas, BB 2015, Acute migraine attacks. in Evidence-Based Neurology: Management of Neurological Disorders: Second Edition. Wiley Blackwell, pp. 267-278. https://doi.org/10.1002/9781119067344.ch26
Anne Macgregor E, Halker RB, Vargas BB. Acute migraine attacks. In Evidence-Based Neurology: Management of Neurological Disorders: Second Edition. Wiley Blackwell. 2015. p. 267-278 https://doi.org/10.1002/9781119067344.ch26
Anne Macgregor, E. ; Halker, Rashmi B. ; Vargas, Bert B. / Acute migraine attacks. Evidence-Based Neurology: Management of Neurological Disorders: Second Edition. Wiley Blackwell, 2015. pp. 267-278
@inbook{d00ce2aca25b46bd99359967b4c5ddd8,
title = "Acute migraine attacks",
abstract = "Headache is the most common neurological condition in the world, with more than 90{\%} of the population reporting headaches at some time in their lives. Among primary headache disorders, tension-type headache is the most prevalent worldwide, but in patients seeking medical help, migraine is by far the most frequently presenting headache subtype. Migraine is more prevalent than diabetes, epilepsy, and asthma combined. Prophylactic drugs aim to reduce the frequency of migraine attacks, their duration, and their severity. Agents used include antihypertensives (including beta-blockers and calcium-channel blockers), antidepressants, anticonvulsants, and NSAIDs. A number of physical treatments for migraine have been studied, including transcutaneous electrical nerve stimulation (TENS), occlusal adjustment, cervical manipulation, and acupuncture. There is extensive clinical experience of using beta-blockers in the prophylaxis of migraine. In general, the prognosis of migraine is favorable.",
keywords = "Acute migraine attacks, Antidepressants, Beta-blockers, Headache, NSAIDs",
author = "{Anne Macgregor}, E. and Halker, {Rashmi B.} and Vargas, {Bert B.}",
year = "2015",
month = "12",
day = "11",
doi = "10.1002/9781119067344.ch26",
language = "English (US)",
isbn = "9780470657782",
pages = "267--278",
booktitle = "Evidence-Based Neurology",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Acute migraine attacks

AU - Anne Macgregor, E.

AU - Halker, Rashmi B.

AU - Vargas, Bert B.

PY - 2015/12/11

Y1 - 2015/12/11

N2 - Headache is the most common neurological condition in the world, with more than 90% of the population reporting headaches at some time in their lives. Among primary headache disorders, tension-type headache is the most prevalent worldwide, but in patients seeking medical help, migraine is by far the most frequently presenting headache subtype. Migraine is more prevalent than diabetes, epilepsy, and asthma combined. Prophylactic drugs aim to reduce the frequency of migraine attacks, their duration, and their severity. Agents used include antihypertensives (including beta-blockers and calcium-channel blockers), antidepressants, anticonvulsants, and NSAIDs. A number of physical treatments for migraine have been studied, including transcutaneous electrical nerve stimulation (TENS), occlusal adjustment, cervical manipulation, and acupuncture. There is extensive clinical experience of using beta-blockers in the prophylaxis of migraine. In general, the prognosis of migraine is favorable.

AB - Headache is the most common neurological condition in the world, with more than 90% of the population reporting headaches at some time in their lives. Among primary headache disorders, tension-type headache is the most prevalent worldwide, but in patients seeking medical help, migraine is by far the most frequently presenting headache subtype. Migraine is more prevalent than diabetes, epilepsy, and asthma combined. Prophylactic drugs aim to reduce the frequency of migraine attacks, their duration, and their severity. Agents used include antihypertensives (including beta-blockers and calcium-channel blockers), antidepressants, anticonvulsants, and NSAIDs. A number of physical treatments for migraine have been studied, including transcutaneous electrical nerve stimulation (TENS), occlusal adjustment, cervical manipulation, and acupuncture. There is extensive clinical experience of using beta-blockers in the prophylaxis of migraine. In general, the prognosis of migraine is favorable.

KW - Acute migraine attacks

KW - Antidepressants

KW - Beta-blockers

KW - Headache

KW - NSAIDs

UR - http://www.scopus.com/inward/record.url?scp=85017991504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017991504&partnerID=8YFLogxK

U2 - 10.1002/9781119067344.ch26

DO - 10.1002/9781119067344.ch26

M3 - Chapter

SN - 9780470657782

SP - 267

EP - 278

BT - Evidence-Based Neurology

PB - Wiley Blackwell

ER -